Form 4 for RMD ResMed|
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-10 · accession 0001127602-22-025406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-11-14 | 2022-11-10 | RMD | Farrell Michael J. | CEO | G - Gift | $0.00 | 0 | 4,090 | New | $0 |
| I | 2022-11-14 | 2022-11-10 | RMD | Farrell Michael J. | CEO | S - Sale | $220.83 | -4,880 | 0 | -100% | -$1.08M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-10 | G | A | 1,000 | $0.00 | 4,880 | I Lisette and Michael Farrell Foundation | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-10 | S | D | 4,880 | $220.83 | 0 | I Lisette and Michael Farrell Foundation | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $220.67 $220.97. The price reported above reflects the weighted average sale price. |
| 3 | Common | ResMed Common Stock | 2022-11-10 | G | D | 1,000 | $0.00 | 4,090 | I Lisette and Michael Farrell Family Trust | — | — |